In conclusion, this randomized, controlled trial demonstrates that IL-17A and TNF-α play an inflammatory role in the acute and subacute stages of stroke and aggravate brain injury, while VEGF-A exerts a neuroprotective effect. This evidence concerns the gene IL17A and stroke disorder.